The global assisted reproductive technology market was estimated to be US$ 25.04 Billion in 2022 and is expected to reach US$ 66.74 Billion by 2032 at a CAGR of 10.3%.
Assisted Reproductive Technology (ART) refers to a range of medical techniques and procedures used to treat infertility and help individuals or couples achieve pregnancy when natural methods are not successful. ART involves the manipulation of eggs, sperm, or embryos outside of the body, typically in a laboratory setting, to facilitate fertilization and implantation.
ART procedures are typically performed by fertility specialists in specialized clinics or hospitals, and the specific procedure or combination of procedures used may vary depending on the individual or couple's fertility diagnosis, medical history, and other factors. ART has helped many individuals and couples overcome infertility and achieve their dream of parenthood, but it can be complex, costly, and may involve ethical and legal considerations. It's important to consult with qualified healthcare professionals for appropriate evaluation, guidance, and management of infertility and ART options.
The global prevalence of infertility has been increasing due to various factors, leading to a growing demand for Assisted Reproductive Technology (ART) services. Changing lifestyles, increasing age at which couples try to conceive, environmental factors, and medical conditions are some of the factors contributing to infertility. Advancements in ART technologies and techniques have also contributed to the growth of the ART market. Innovations in IVF laboratory equipment, cryopreservation techniques, embryo culture systems, and genetic screening technologies have improved the success rates of ART procedures and expanded treatment options for patients.
Furthermore, there has been a growing awareness among the general population about ART and its potential for helping couples and individuals achieve pregnancy. Increased awareness through educational campaigns, media coverage, and patient testimonials about successful pregnancies through ART has led to more patients seeking ART services and a higher acceptance of ART as a viable option for overcoming infertility in society.
Based on procedure type, In-Vitro Fertilization (IVF) is the largest segment in the global Assisted Reproductive Technology (ART) market. IVF involves the fertilization of eggs with sperm outside the body in a laboratory setting, followed by transferring the resulting embryos into the uterus for implantation. IVF is a widely adopted ART procedure due to its higher success rates and ability to address various causes of infertility, such as fallopian tube blockage, low sperm count, and unexplained infertility.
IVF has become the preferred choice for many couples and individuals struggling with infertility, as it offers higher chances of achieving pregnancy compared to other ART procedures. Moreover, advancements in IVF technologies and techniques, such as blastocyst culture, preimplantation genetic testing (PGT), and cryopreservation, have further improved the success rates of IVF, making it the largest segment in the ART market.
Additionally, IVF has gained popularity globally due to the increasing awareness about ART and its success rates, along with the expanding access to ART services in many countries. The growing acceptance and adoption of IVF as a viable option for overcoming infertility have contributed to its dominant position in the ART market, making it the largest segment among the listed procedure types.
Geographically, the global assisted reproductive technology market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America.
Following are some of the major trends in these regions –
North America: North America is a significant market for ART, with the United States being the largest contributor to the region's ART market. The region is characterized by a high prevalence of infertility, advanced healthcare infrastructure, and favorable reimbursement policies, which contribute to the growth of the ART market. In addition, increasing awareness about ART and higher adoption of advanced ART technologies and techniques are driving the growth of the ART market in North America.
Europe: Europe is another prominent market for ART, with countries like Germany, France, and the United Kingdom being major contributors to the region's ART market. The region has a well-developed healthcare system, increasing prevalence of infertility, and supportive regulatory frameworks, which foster the growth of the ART market in Europe. Additionally, advancements in ART technologies, growing awareness, and increasing acceptance of ART procedures are driving the demand for ART services in the region.
Asia-Pacific: The Asia-Pacific region is witnessing rapid growth in the ART market, driven by factors such as increasing disposable income, changing lifestyles, growing awareness about infertility, and advancements in healthcare infrastructure. Countries like China, India, and Japan are major contributors to the ART market in Asia-Pacific.
Middle East and Africa: The Middle East and Africa region is experiencing steady growth in the ART market, albeit at a slower pace compared to other regions. The region has a relatively lower prevalence of infertility compared to other regions, and cultural, religious, and social factors may impact the demand for ART services. However, increasing awareness about ART, rising demand for infertility treatments, and improving healthcare infrastructure are expected to drive the growth of the ART market in the Middle East and Africa.
South America: South America is also witnessing growth in the ART market, driven by factors such as increasing prevalence of infertility, improving healthcare infrastructure, and growing awareness about ART procedures. Countries like Brazil, Argentina, and Colombia are major contributors to the ART market in South America. However, economic and regulatory challenges may impact the growth of the ART market in the region to some extent.
Companies operating in the global Assisted Reproductive Technology (ART) market adopt various growth strategies to expand their market presence and gain a competitive edge.
Some of the major growth strategies commonly observed in the ART market include:
Product portfolio expansion: Companies often focus on expanding their product portfolio to offer a diverse range of ART services and solutions. This may include the introduction of new ART technologies, devices, and equipment, as well as the development of innovative techniques and protocols for ART procedures. Product portfolio expansion allows companies to cater to the evolving needs of patients and healthcare providers, and capture a larger share of the ART market.
Geographic expansion: Companies may expand their geographic presence by entering new markets or expanding their operations in existing markets. This may involve setting up new ART clinics, laboratories, or distribution channels in regions with high demand for ART services. Geographic expansion allows companies to tap into new patient populations, leverage local resources, and capitalize on emerging opportunities in different regions.
Partnerships and collaborations: Companies may form strategic partnerships or collaborations with other players in the ART market, such as hospitals, fertility clinics, research institutes, or technology providers. Such partnerships can provide access to complementary expertise, resources, and technologies, and help companies expand their capabilities and offerings in the ART market. Collaborations can also accelerate research and development efforts, enhance market reach, and create synergies for mutual benefit.
Mergers and acquisitions: Mergers and acquisitions (M&A) are common strategies in the ART market, aimed at consolidating market share, acquiring new technologies or expertise, and gaining competitive advantage. M&A activities can enable companies to achieve economies of scale, expand their customer base, enhance their product portfolio, and strengthen their market position.
Marketing and promotional activities: Companies may invest in marketing and promotional activities to create awareness about their ART services, build brand reputation, and attract more patients. This may involve digital marketing, social media campaigns, participation in industry events and conferences, and other promotional activities targeted towards patients, healthcare providers, and other stakeholders.
Cook Medical, CooperSurgical, Inc., Ferring Pharmaceuticals, Genea Limited, IGENOMIX, INVO Bioscience, IVFtech ApS, Merck KGaA, Nidacon International AB, OvaScience, Progyny, Inc., Vitrolife AB, Anecova, CryoChoice, ReproTech Ltd. and many more.
By Procedure Type:
By End User:
The assisted reproductive technology market size is expected to reach US$ 66.74 Billion by 2032.
The assisted reproductive technology market is expected to grow at a CAGR of 10.3% from 2023 to 2032.
The assisted reproductive technology market size was estimated to be US$ 25.04 Billion in 2022.
Advancements in ART technologies and techniquesa and global prevalence of infertility has been increasing due to various factors are expected to drive Assisted Reproductive Technology (ART) market growth during the forecast period.
In-Vitro Fertilization (IVF) is the largest procedure type in the global Assisted Reproductive Technology (ART) market. The growing acceptance and adoption of IVF as a viable option for overcoming infertility have contributed to its dominant position in the ART market, making it the largest segment among the listed procedure types.
United States is the largest contributor to the North America assisted reproductive technology (ART) market.
Europe is prominent market for assisted reproductive technology. The region has a well-developed healthcare system, increasing prevalence of infertility, and supportive regulatory frameworks, which foster the growth of the ART market in Europe.
The procedure types of assisted reproductive technology include In-Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Transfer (FET), Donor Egg IVF, Surrogacy, others.
Cook Medical, CooperSurgical, Inc., Ferring Pharmaceuticals, Genea Limited, IGENOMIX, INVO Bioscience, IVFtech ApS, Merck KGaA, Nidacon International AB, OvaScience, Progyny, Inc., Vitrolife AB, Anecova, CryoChoice, ReproTech Ltd. among others, are the prominent players in this market.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved